We hypothesize that the altered expression of ALDOC in NSCLC could disrupt glucose metabolism and other metabolic processes, resulting in changes in the transcriptional profile of NSCLC cells and patient samples. This evidence concerns the gene ALDOC and non-small cell lung carcinoma.